BusinessEarningsNews
0

Lexaria Bioscience Earnings Analysis: Q1 Recap

Lexaria Bioscience LEXX just disclosed its Q1 earnings on Friday, January 10, 2025 at 02:19 PM.

Here’s a brief overview of the earnings report.

Earnings

Lexaria Bioscience missed estimated earnings by -33.0%, reporting an EPS of $-0.16 versus an estimate of $-0.12.

Revenue was up $32 thousand from the same period last year.

Earnings History Overview

During the previous quarter, the company missed on EPS by $0.04, leading to a 2.0% drop share price change the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Lexaria Bioscience visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

More Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed